BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 26148816)

  • 1. Tandem repeat recombinant proteins as potential antigens for the sero-diagnosis of Schistosoma mansoni infection.
    Kalenda YD; Kato K; Goto Y; Fujii Y; Hamano S
    Parasitol Int; 2015 Dec; 64(6):503-12. PubMed ID: 26148816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of serological responses to defined recombinant proteins during Schistosoma mansoni infection in mice before and after the treatment with praziquantel.
    Mohammed ES; Nakamura R; Kalenda YD; Deloer S; Moriyasu T; Tanaka M; Fujii Y; Kaneko S; Hirayama K; Ibrahim AI; El-Seify MA; Metwally AM; Hamano S
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008518. PubMed ID: 32915790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of Schistosoma mansoni infection by touchdown PCR in a mouse model.
    Suzuki T; Osada Y; Kumagai T; Hamada A; Okuzawa E; Kanazawa T
    Parasitol Int; 2006 Sep; 55(3):213-8. PubMed ID: 16822708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schistosoma mansoni antigens applicable to diagnosis of prepatent infections.
    Mikhail MM; Mansour MM; Farid Z; Harrison R
    J Egypt Soc Parasitol; 1997 Apr; 27(1):1-20. PubMed ID: 9097522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
    Farah IO; Johansson M; Lövgren-Bengtson K; Hau J
    Scand J Immunol; 2000 Mar; 51(3):237-43. PubMed ID: 10736092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schistosoma mansoni and S. japonicum: decline of antibodies against diagnostic adult worm antigens (Sm31/32) following praziquantel treatment of mice.
    Ruppel A; Xing Y; Dell R; Numrich P; Shi YE
    Trop Med Parasitol; 1991 Dec; 42(4):325-31. PubMed ID: 1796226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological analysis of the outcome of treatment of Schistosoma mansoni infections with praziquantel.
    Bligh J; Schramm G; Chiodini PL; Doenhoff MJ
    Ann Trop Med Parasitol; 2010 Sep; 104(6):511-20. PubMed ID: 20863440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological analysis of cloned Schistosoma mansoni antigens Sm31 and Sm32 with sera of schistosomiasis patients.
    Klinkert MQ; Bommert K; Moser D; Felleisen R; Link G; Doumbo O; Beck E
    Trop Med Parasitol; 1991 Dec; 42(4):319-24. PubMed ID: 1796225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human IgG1 Responses to Surface Localised Schistosoma mansoni Ly6 Family Members Drop following Praziquantel Treatment.
    Chalmers IW; Fitzsimmons CM; Brown M; Pierrot C; Jones FM; Wawrzyniak JM; Fernandez-Fuentes N; Tukahebwa EM; Dunne DW; Khalife J; Hoffmann KF
    PLoS Negl Trop Dis; 2015; 9(7):e0003920. PubMed ID: 26147973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: Diagnosis and Assessment of Cure Approaches for Acute Schistosomiasis in Pre-School Children.
    Cavalcanti MG; Engel DC; de Araujo Cunha AF; Peralta JM
    Front Immunol; 2021; 12():624736. PubMed ID: 34054799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trial.
    Tweyongyere R; Mawa PA; Emojong NO; Mpairwe H; Jones FM; Duong T; Dunne DW; Vennervald BJ; Katunguka-Rwakishaya E; Elliott AM
    BMC Infect Dis; 2009 Mar; 9():32. PubMed ID: 19296834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schistosoma mansoni gene GP22 encodes the tegumental antigen sm25: (1) antibodies to a predicted B-cell epitope of Sm25 cross-react with other candidate vaccine worm antigens; (2) characterization of a recombinant product containing tandem-repeats of this peptide as a vaccine.
    Petzke MM; Suri PK; Bungiro R; Goldberg M; Taylor SF; Ranji S; Taylor H; McCray JW; Knopf PM
    Parasite Immunol; 2000 Aug; 22(8):381-95. PubMed ID: 10972845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCHISTOSOMA MANSONI INFECTION AND THE ASSOCIATED ANTIBODY IMMUNE RESPONSE AMONGST RESIDENTS OF KIGUNGU ENTEBBE, UGANDA.
    Odongo-Aginya EI; Wilson RA; Kyabayinze D; Sempewo H; Oliveira RC; Kironde F
    East Afr Med J; 2012 Apr; 89(4):111-20. PubMed ID: 26856035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological proteomic screening and evaluation of a recombinant egg antigen for the diagnosis of low-intensity Schistosoma mansoni infections in endemic area in Brazil.
    Silva-Moraes V; Shollenberger LM; Castro-Borges W; Rabello ALT; Harn DA; Medeiros LCS; Jeremias WJ; Siqueira LMV; Pereira CSS; Pedrosa MLC; Almeida NBF; Almeida A; Lambertucci JR; Carneiro NFF; Coelho PMZ; Grenfell RFQ
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0006974. PubMed ID: 30870412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosoma mansoni: IgG reactivity to soluble adult worm antigen preparation (SWAP) in sera of immunized mice with irradiated attenuated and virulent cercariae.
    Hanna LS; Mohamed MI; Botros SS
    J Egypt Soc Parasitol; 1994 Dec; 24(3):553-68. PubMed ID: 7844419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosoma mansoni: molecular cloning and sequencing of the 200-kDa chemotherapeutic target antigen.
    Hall TM; Joseph GT; Strand M
    Exp Parasitol; 1995 Mar; 80(2):242-9. PubMed ID: 7534724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of mice with crude extract of Saccharomyces boulardii yeast induces cross-reactive immune responses with antigenic preparations from different developmental stages of the Schistosoma mansoni and reduces the parasite worm burden.
    Bahgat M; Maghraby AS; Ab Del-Fatah OM; Elshafei AM
    J Egypt Soc Parasitol; 2005 Aug; 35(2):563-80. PubMed ID: 16083068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of Schistosoma mansoni tegument annexins and comparative analysis of antibody responses following parasite infection.
    Leow CY; Willis C; Leow CH; Hofmann A; Jones M
    Mol Biochem Parasitol; 2019 Dec; 234():111231. PubMed ID: 31628972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attempts to induce resistance in mice to Schistosoma japonicum and Schistosoma mansoni by exposure to crude schistosome antigens plus cloned glutathione-S-transferases.
    Mitchell GF; Davern KM; Wood SM; Wright MD; Argyropoulos VP; McLeod KS; Tiu WU; Garcia EG
    Immunol Cell Biol; 1990 Dec; 68 ( Pt 6)():377-85. PubMed ID: 2129038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.